Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: Role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway

Molecular Pharmacology

Volumn 80, Issue 6, 2011, Pages 1166-1178

  Hien, Tran Thi ^a,c   Oh, Won Keun ^a   Nguyen, Phi Hung ^a   Oh, Seok Jeong ^b   Lee, Moo Yeol ^b   Kang, Keon Wook ^c  

^a Chosun University   (South Korea)

^b Dongguk University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; NECTANDRIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EVOKED RESPONSE; HUMAN; HUMAN CELL; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VASCULAR RING; VASODILATATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; HUMANS; LIGNANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN CULTURE TECHNIQUES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 81555195472     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.073502     Document Type: Article

References (54)

1. Afrose S, Hossain MS, Maki T, and Tsujii H (2009) Karaya root saponin exerts a hypocholesterolemic response in rats fed a high-cholesterol diet. Nutr Res 29:350-354.
2. Anggakusuma, Yanti, and Hwang JK (2010) Effects of macelignan isolated from Myristica fragrans Houtt. on UVB-induced matrix metalloproteinase-9 and cyclooxygenase-2 in HaCaT cells. J Dermatol Sci 57:114-122.
3. 2+ entry via TRPC channels is necessary for thrombin-induced NF-κB activation in endothelial cells through AMP-activated protein kinase and protein kinase Cδ. J Biol Chem 284:563-574.
4. Bradley EA, Eringa EC, Stehouwer CD, Korstjens I, van Nieuw Amerongen GP, Musters R, Sipkema P, Clark MG, and Rattigan S (2010) Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D- ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion. Arterioscler Thromb Vasc Biol 30:1137-1142.
5. Cai H, Li Z, Davis ME, Kanner W, Harrison DG, and Dudley SC Jr (2003) Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol 63:325-331. (Pubitemid 36158367)
6. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, and Nakshatri H (2001) Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 276:9817-9824.
7. Carling D (2004) The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 29:18-24.
8. Carling D, Sanders MJ, and Woods A (2008) The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 32 (Suppl 4):S55-S59.
9. Chakrabarti S and Davidge ST (2009) High glucose-induced oxidative stress alters estrogen effects on ERalpha and ERbeta in human endothelial cells: reversal by AMPK activator. J Steroid Biochem Mol Biol 117:99-106.
10. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289. (Pubitemid 29080812)
11. Colombo SL and Moncada S (2009) AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421:163-169.
12. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605.
13. Dong Y, Zhang M, Wang S, Liang B, Zhao Z, Liu C, Wu M, Choi HC, Lyons TJ, and Zou MH (2010) Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes 59:1386-1396.
14. Fatehi-Hassanabad Z, Chan CB, and Furman BL (2010) Reactive oxygen species and endothelial function in diabetes. Eur J Pharmacol 636:8-17.
15. Formoso G, Chen H, Kim JA, Montagnani M, Consoli A, and Quon MJ (2006) Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium. Mol Endocrinol 20:1153-1163.
16. Fujimoto N, Kohta R, and Kitamura S (2004) Estrogenic activity of an antioxidant, nordihydroguaiaretic acid (NDGA). Life Sci 74:1417-1425. (Pubitemid 38045534)
17. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601.
18. Go YM, Levonen AL, Moellering D, Ramachandran A, Patel RP, Jo H, and Darley-Usmar VM (2001) Endothelial NOS-dependent activation of c-Jun NH(2)- terminal kinase by oxidized low-density lipoprotein. Am J Physiol Heart Circ Physiol 281:H2705-H2713.
19. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, and Vita JA (2003) Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41:1769-1775. (Pubitemid 36584251)
20. Grossini E, Molinari C, Caimmi PP, Uberti F, and Vacca G (2009) Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel. Br J Pharmacol 156:250-261.
21. Grossini E, Molinari C, Mary DA, Uberti F, Caimmi PP, Surico N, and Vacca G (2008) Intracoronary genistein acutely increases coronary blood flow in anesthetized pigs through beta-adrenergic mediated nitric oxide release and estrogenic receptors. Endocrinology 149:2678-2687. (Pubitemid 351574501)
22. Grover JK, Khandkar S, Vats V, Dhunnoo Y, and Das D (2002) Pharmacological studies on Myristica fragrans-antidiarrheal, hypnotic, analgesic and hemodynamic (blood pressure) parameters. Methods Find Exp Clin Pharmacol 24:675-680. (Pubitemid 36188275)
23. Han CY, Cho KB, Choi HS, Han HK, and Kang KW (2008a) Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells. Carcinogenesis 29:1837-1844.
24. Han KL, Choi JS, Lee JY, Song J, Joe MK, Jung MH, and Hwang JK (2008b) Therapeutic potential of peroxisome proliferators-activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes 57:737-745.
25. Hardie DG (2007) AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 47:185-210.
26. Hardie DG and Hawley SA (2001) AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112-1119.
27. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC, and Bender JR (2003) Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 278:2118-2123. (Pubitemid 36801275)
28. Howes LG, Abbott D, and Straznicky NE (1997) Lipoproteins and cardiovascular reactivity. Br J Clin Pharmacol 44:319-324. (Pubitemid 27402105)
29. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280:29060-29066.
30. Kan WH, Hsu JT, Ba ZF, Schwacha MG, Chen J, Choudhry MA, Bland KI, and Chaudry IH (2008) p38 MAPK-dependent eNOS upregulation is critical for 17beta-estradiol-mediated cardioprotection following trauma-hemorrhage. Am J Physiol Heart Circ Physiol 294:H2627-H2636.
31. Katsuda S, Suzuki K, Koyama N, Takahashi M, Miyake M, Hazama A, and Takazawa K (2009) Safflower seed polyphenols (N-(p-coumaroyl)serotonin and N-feruloylserotonin) ameliorate atherosclerosis and distensibility of the aortic wall in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Hypertens Res 32:944-949.
32. Kwon HS, Kim MJ, Jeong HJ, Yang MS, Park KH, Jeong TS, and Lee WS (2008) Low-density lipoprotein (LDL)-antioxidant lignans from Myristica fragrans seeds. Bioorg Med Chem Lett 18:194-198.
33. Levine YC, Li GK, and Michel T (2007) Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK ->Rac1 -> Akt -> endothelial nitric-oxide synthase pathway. J Biol Chem 282:20351-20364. (Pubitemid 47100039)
34. Li H and Förstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244-254. (Pubitemid 30141371)
35. Ma J, Hwang YK, Cho WH, Han SH, Hwang JK, and Han JS (2009) Macelignan attenuates activations of mitogen-activated protein kinases and nuclear factor kappa B induced by lipopolysaccharide in microglial cells. Biol Pharm Bull 32:1085-1090.
36. Magnone M, Bruzzone S, Guida L, Damonte G, Millo E, Scarfì Si C, Sturla L, Palombo D, De Flora A, and Zocchi E (2009) Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis. J Biol Chem 284:17808-17818.
37. Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, and Kamata K (2008) Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 295:H1165-H1176.
38. Merla R, Ye Y, Lin Y, Manickavasagam S, Huang MH, Perez-Polo RJ, Uretsky BF, and Birnbaum Y (2007) The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. Am J Physiol Heart Circ Physiol 293:H1918-H1928. (Pubitemid 47367243)
39. Michell BJ, Chen Zp, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, and Kemp BE (2001) Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 276:17625-17628.
40. Mineo C and Shaul PW (2006) Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc Res 70:31-41.
41. Misra P (2008) AMP activated protein kinase: a next generation target for total metabolic control. Expert Opin Ther Targets 12:91-100.
42. Moncada S and Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012. (Pubitemid 24015045)
43. Morcos M, Borcea V, Isermann B, Gehrke S, Ehret T, Henkels M, Schiekofer S, Hofmann M, Amiral J, Tritschler H, et al. (2001) Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract 52:175-183. (Pubitemid 32385330)
44. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, and Salt IP (2003) Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 278:31629-31639. (Pubitemid 37048341)
45. Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, Kemp BE, and Power DA (2008) Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis 200:28-36.
46. Namkoong S, Kim CK, Cho YL, Kim JH, Lee H, Ha KS, Choe J, Kim PH, Won MH, Kwon YG, et al. (2009) Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cell Signal 21:906-915.
47. Nguyen PH, Le TV, Kang HW, Chae J, Kim SK, Kwon KI, Seo DB, Lee SJ, and Oh WK (2010) AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect. Bioorg Med Chem Lett 20:4128-4131.
48. Schalkwijk CG and Stehouwer CD (2005) Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 109:143-159. (Pubitemid 41117297)
49. Sharma A, Mathur R, and Dixit VP (1995) Prevention of hypercholesterolemia and atherosclerosis in rabbits after supplementation of Myristica fragrans seed extract. Indian J Physiol Pharmacol 39:407-410.
50. Shiojima I and Walsh K (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90:1243-1250. (Pubitemid 34787405)
51. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, and Liao JK (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541.
52. Thomas SR, Chen K, and Keaney JF Jr (2002) Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem 277:6017-6024. (Pubitemid 34968385)
53. Widlansky ME, Gokce N, Keaney JF Jr, and Vita JA (2003) The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42:1149-1160. (Pubitemid 37188333)
54. 2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21-33.